Sign in

    Vlad Vitoc

    Chief Executive Officer at Maia Biotechnology Inc
    Board
    Since September 2018
    Age
    55 years
    Education
    Holds an M.D. from the University of Medicine and Pharmacy "Iuliu Hatieganu" in Cluj-Napoca, Romania, and an M.B.A. from the University of South Carolina.
    Tenure
    Founded MAIA and has served as Chairman, Chief Executive Officer, and President since September 2018.

    Also at Maia Biotechnology Inc

    JH
    Jeffrey Himmelreich
    Head of Finance and Principal Financial and Accounting Officer
    SMG
    Sergei M. Gryaznov
    Chief Scientific Officer

    About

    The executive holds an M.D. from the University of Medicine and Pharmacy "Iuliu Hatieganu" in Cluj-Napoca, Romania, and an M.B.A. from the University of South Carolina, demonstrating a strong educational foundation in both medicine and business.

    With over 20 years of experience in the pharmaceutical and biotechnology industries, he has led initiatives at multiple prominent companies such as Bayer, Astellas Pharma Inc., Cephalon Inc., and Incyte Corporation. His expertise in commercial strategic analysis and medical affairs spans the development of targeted and immune therapies across more than 25 tumor types.

    As a co-founder of MAIA Biotechnology, he has been instrumental in shaping the company’s direction by serving as Chairman, Chief Executive Officer, and President since September 2018. Under his leadership, the company has focused on advancing novel cancer treatments, expanding its intellectual property portfolio, and progressing its clinical programs.

    $MAIA Performance Under Vlad Vitoc

    Past Roles

    OrganizationRoleDate RangeDetails
    Incyte Corporation Leadership Positions N/A [N/A]Worked on targeted therapies and immune therapies across multiple tumor types
    Cephalon Inc. Leadership Team Member N/A [N/A]Contributed to the development and commercialization of oncology brands
    Astellas Pharma Inc. Leadership Roles N/A [N/A]Focused on oncology-related business units
    Bayer Pharmaceuticals Leadership Roles N/A [N/A]Involved in oncology development and commercialization efforts

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$473,000 N/AAnnual base salary for 2023
    Option Awards$900,934 N/AValued based on aggregate grant date fair value per ASC Topic 718; subject to vesting conditions
    All Other Compensation$56,823 N/AIncludes medical premiums and a 401(k) match

    Performance Compensation

    Data from  FY 2023

    No information available on performance compensation for 2023